Table 2.
Effect of Ad-36 seropositivity on clinical and biochemical measurements.
| Measurements | Without adjusted | Multiple models* | ||
|---|---|---|---|---|
| β (95% CI) | P value | β (95% CI) | P value | |
| Weight (kg) | 2.54 (−1.91–7.0) | 0.26 | 3.18 (−0.45–6.8) | 0.08 |
| BMI (kg/m2) | 1.46 (−0.02–2.95) | 0.05 | 1.58 (0.12–3.04) | 0.03 |
| Systolic BP (mmHg) | 2.67 (−0.66–6.0) | 0.11 | 2.65 (−0.61–5.92) | 0.11 |
| Diastolic BP (mmHg) | 0.50 (−1.82–2.82) | 0.67 | 0.54 (−1.69–2.79) | 0.63 |
| Waist circumference (cm) | 1.55 (−2.38–5.5) | 0.43 | 1.83 (−1.82–5.48) | 0.32 |
| Arm circumference (cm) | 0.54 (−0.81–1.89) | 0.43 | 0.67 (−0.57–1.93) | 0.28 |
| Total cholesterol (mg/dL) | 8.78 (−2.12–19.7) | 0.11 | 8.71 (−2.32–19.7) | 0.12 |
| Triglycerides (mg/dL) | 18.6 (0.05–37.1) | 0.05 | 18.7 (−0.1–37.5) | 0.05 |
| HDL-c (mg/dL) | −3.24 (−11.5–5.0) | 0.43 | −2.97 (−11.3–5.34) | 0.48 |
| LDL-c (mg/dL) | 6.0 (−7.2–19.2) | 0.36 | 5.52 (−7.63–18.7) | 0.40 |
| Glucose (mg/dL) | 2.95 (−0.76–6.67) | 0.11 | 2.75 (−0.93–6.45) | 0.14 |
| Insulin (µU/mL) | 1.93 (−1.4–5.27) | 0.25 | 2.09 (−1.28–5.47) | 0.22 |
| HOMA | 0.52 (−0.17–1.22) | 0.13 | 0.54 (−0.15–1.24) | 0.12 |
Regression coefficient (95% CI). *Adjusted by age and gender.